drugset

drugset / Trial / NCT00790660

A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.

NCT00790660 ↗

Phase 2 Completed 61 enrolled Astellas Pharma Inc

RandomizedParallel-groupDouble-blindTreatment

Summary

This study is intended to assess safety and tolerability of ASP1941 compared to placebo in adult subjects with type 2 diabetes mellitus

Timeline

Start: 2008-10-23
Primary completion: 2009-03-06
Completion: 2009-03-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ipragliflozin	Small molecule	—	Oral

Indications